Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Cash from Financing Activities (2021 - 2025)

Tenon Medical has reported Cash from Financing Activities over the past 5 years, most recently at $2.7 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at $2.7 million for Q4 2025, up 2315.93% from a year ago — trailing twelve months through Dec 2025 was $9.0 million (down 36.36% YoY), and the annual figure for FY2025 was $9.0 million, down 36.36%.
  • Cash from Financing Activities for Q4 2025 was $2.7 million at Tenon Medical, up from $59000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for TNON hit a ceiling of $14.2 million in Q2 2022 and a floor of -$179000.0 in Q4 2021.
  • Median Cash from Financing Activities over the past 5 years was $818500.0 (2023), compared with a mean of $3.1 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 10507.14% in 2024 and later plummeted 99.39% in 2025.
  • Tenon Medical's Cash from Financing Activities stood at -$179000.0 in 2021, then skyrocketed by 86.03% to -$25000.0 in 2022, then surged by 5584.0% to $1.4 million in 2023, then tumbled by 91.76% to $113000.0 in 2024, then skyrocketed by 2315.93% to $2.7 million in 2025.
  • The last three reported values for Cash from Financing Activities were $2.7 million (Q4 2025), $59000.0 (Q3 2025), and -$59000.0 (Q2 2025) per Business Quant data.